We guide patients and healthcare providers toward the recognition, early detection, and prevention of a broad spectrum of cardiometabolic diseases.

We guide patients, at-risk individuals, and institutions toward strategies for achieving the rapid regression of accelerated, tumultuous, pure thrombotic events (including venous, arterial, cardiac, cerebral, and peripheral, as well as retinal sites) and atherothrombotic courses. Even severe pulmonary embolisms have been successfully resolved without pharmacological intervention in cases where contraindications existed.

Furthermore, we assist in identifying vasoconstrictive coronary and systemic arterial syndromes, which can destabilize otherwise manageable vascular conditions, driving them toward acute atherothrombosis.

In cases of overt diagnosis, we assist patients and healthcare facilities in screening whether a condition can be redirected toward its initial stages and, where possible, reverted to milder clinical presentations or a near-healthy state.

Any acute form of food allergy, particularly when manifesting as diarrhea, must be promptly managed with antihistamines and medical observation. Subsequently, screening for any form of cysticercal contamination should be conducted.

In the absence of alternative diagnoses, any sustained or unexplained diarrhea must be considered highly likely to be related to cysticercosis—given the gut’s role as a sanctuary for the infection. Such cases require rapid intervention through modalities such as Hyperbaric Oxygen Therapy (HBOT), even when available at home, to address the anaerobic nature of the pathogen.

An increasing number of severe allergic manifestations may occur in individuals with no prior history of atopy or allergies. These can be of such high clinical significance as to result in anaphylactic shock.

Bouts of histamine release severe enough to produce clinical manifestations may follow a reactivation of cysticercosis. Such triggers include viral infections, prolonged exposure to hypoxia (e.g., high-altitude stays or air travel), or adverse drug reactions [1.1, 1.2].
Clinical consequences range from hyperacute "allergic" non-eosinophilic hypersensitivity pneumonitis to sustained hypertensive states and crises. These may progress to localized tissue damage and focal parenchymal necrosis, affecting the pancreas (potentially leading to new-onset diabetes), the cardiac conduction system (resulting in heart block or sinus node dysfunction), the kidneys, and other organs [1.2, 1.3].

Various allergic stimuli—particularly those affecting the lungs and airways, such as viral infections, cold exposure, or certain toxic medications (e.g., amiodarone, even in trace amounts)—can trigger severe, hyperacute pulmonary manifestations. These life-threatening events, which may cause oxygen saturation (SpO2) to drop as low as 84% on digital oximetry, require immediate intervention with antihistamines and supplemental oxygen. Clinical evidence suggests a near-instantaneous response to this protocol, which should be integrated with Hyperbaric Oxygen Therapy (HBOT) cycles whenever possible.

Any new or newly worsened hypertensive manifestation should be evaluated as a potential symptomatic "replicative" phase of vascular cysticercosis. Such phases may be triggered by intercurrent factors—including hypoxia, immunosuppression, or concurrent infections—as well as by medications that facilitate histamine release. This release, in turn, can promote tissue penetration and the active replication of cysticerci.

Caution is advised to provide enhanced antihistamine premedication prior to any radiocontrast-enhanced examination, and for at least 20–30 days thereafter. Pre-existing vascular cysticercosis may undergo an unexpected proliferative surge, exacerbating histamine-mediated vasoconstriction. This can manifest clinically as severe myocardial infarction, mesenteric ischemia (bowel infarction), or acute peripheral vascular disorders. The use of steroids must be strictly avoided, as they may facilitate cysticercus proliferation.